Bialik Medtech Israel

Company Overview

Snapshot

Founded in March 2026, Bialik Medtech Israel operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its continuous vital-sign monitoring platform.

Business overview

Bialik Medtech Israel is developing an AI-assisted platform for continuous vital-sign monitoring, targeting both human and veterinary care. Its core technology includes medical hardware, a secure cloud environment, an AI-powered software layer, and a companion smartphone application designed to track measures such as pulse, blood-oxygen saturation, and temperature 24/7. The company serves clinics and veterinary clinics through hardware and integration projects, with future plans to offer an app for individual users and animal owners. Bialik Medtech Israel operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Monitors.

Company Intelligence Q&A

What is Bialik Medtech Israel's primary focus?

Bialik Medtech Israel is focused on developing an AI-assisted platform for continuous vital-sign monitoring in both human and veterinary care.

When was Bialik Medtech Israel founded?

Bialik Medtech Israel was founded in March 2026.

What markets does Bialik Medtech Israel target?

Bialik Medtech Israel targets clinics and veterinary clinics, with plans to expand to individual users and animal owners.

What technology does Bialik Medtech Israel utilize?

Bialik Medtech Israel's platform integrates medical hardware, a secure cloud environment, an AI-assisted software layer, and a companion smartphone app for vital-sign tracking.

What is Bialik Medtech Israel's current funding stage?

Bialik Medtech Israel is currently in the Pre-Funding stage, indicating it has not yet raised external capital.